Introduction There is a lack of comprehensive cost information for cardiovascular events
since 2013. Objective A systematic review on the contemporary cost of cardiovascular …

Objective This study aims to systematically evaluate available evidence regarding direct
medical costs of treating cardiovascular (CV) events in Germany after 2003 on an individual …

Objective Robust cost estimates of cardiovascular (CV) events are required for assessing
health care interventions aimed at reducing the economic burden of major adverse CV …

Background: In this study, we developed cost prediction equations that facilitate estimation
of the costs of various cardiovascular events for patients of specific demographic and clinical …

Background Cardiovascular diseases are associated with growing public and private
expenditure on healthcare regardless geographic region. Therefore, it is necessary to …

Objective We calculated the short-and long-term care resource use and costs in adults with
high-risk conditions for cardiovascular disease (HRCVD) as defined by the Canadian …

Objectives The aim of this study was to develop prediction models for the individual-level
impacts of cardiovascular events on UK healthcare costs. Methods In the UK Biobank …

Cardiovascular disease (CVD) results in half of the non-communicable disease-related
deaths worldwide. Rising treatment costs have increased the need for cost-utility models …

Objective Many trials of new therapies for cardiovascular disease include economic
measures to assess the impact of treatment on healthcare costs, however, it is difficult to …

Background There is a lack of a uniform proxy for defining direct medical costs in the US.
This potentially important source of variation in modelling and other types of economic …